AstraZeneca: Harbour BioMed inks collaboration with AstraZeneca to discover and develop nextgeneration therapeutic antibodies

Harbour BioMed, a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics in immunology and oncology, announced a global strategic